These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Signature gene expression profile of triclosan-resistant Escherichia coli. Yu BJ; Kim JA; Pan JG J Antimicrob Chemother; 2010 Jun; 65(6):1171-7. PubMed ID: 20410062 [TBL] [Abstract][Full Text] [Related]
7. Discovery of 4-Pyridone derivatives as specific inhibitors of enoyl-acyl carrier protein reductase (FabI) with antibacterial activity against Staphylococcus aureus. Takahata S; Iida M; Yoshida T; Kumura K; Kitagawa H; Hoshiko S J Antibiot (Tokyo); 2007 Feb; 60(2):123-8. PubMed ID: 17420562 [TBL] [Abstract][Full Text] [Related]
8. Resistance to AFN-1252 arises from missense mutations in Staphylococcus aureus enoyl-acyl carrier protein reductase (FabI). Yao J; Maxwell JB; Rock CO J Biol Chem; 2013 Dec; 288(51):36261-71. PubMed ID: 24189061 [TBL] [Abstract][Full Text] [Related]
9. Characterization of Pseudomonas aeruginosa enoyl-acyl carrier protein reductase (FabI): a target for the antimicrobial triclosan and its role in acylated homoserine lactone synthesis. Hoang TT; Schweizer HP J Bacteriol; 1999 Sep; 181(17):5489-97. PubMed ID: 10464225 [TBL] [Abstract][Full Text] [Related]
10. Triclosan resistance of Pseudomonas aeruginosa PAO1 is due to FabV, a triclosan-resistant enoyl-acyl carrier protein reductase. Zhu L; Lin J; Ma J; Cronan JE; Wang H Antimicrob Agents Chemother; 2010 Feb; 54(2):689-98. PubMed ID: 19933806 [TBL] [Abstract][Full Text] [Related]
11. Structural insights into Staphylococcus aureus enoyl-ACP reductase (FabI), in complex with NADP and triclosan. Priyadarshi A; Kim EE; Hwang KY Proteins; 2010 Feb; 78(2):480-6. PubMed ID: 19768684 [No Abstract] [Full Text] [Related]
12. Characterization of a novel enoyl-acyl carrier protein reductase of diazaborine-resistant Rhodobacter sphaeroides mutant. Lee IH; Kim EJ; Cho YH; Lee JK Biochem Biophys Res Commun; 2002 Dec; 299(4):621-7. PubMed ID: 12459184 [TBL] [Abstract][Full Text] [Related]
13. Staphylococcus aureus but not Listeria monocytogenes adapt to triclosan and adaptation correlates with increased fabI expression and agr deficiency. Nielsen LN; Larsen MH; Skovgaard S; Kastbjerg V; Westh H; Gram L; Ingmer H BMC Microbiol; 2013 Jul; 13():177. PubMed ID: 23898801 [TBL] [Abstract][Full Text] [Related]
15. The prevalence and mechanism of triclosan resistance in Escherichia coli isolated from urine samples in Wenzhou, China. Zeng W; Xu W; Xu Y; Liao W; Zhao Y; Zheng X; Xu C; Zhou T; Cao J Antimicrob Resist Infect Control; 2020 Oct; 9(1):161. PubMed ID: 33008474 [TBL] [Abstract][Full Text] [Related]
16. Reduced Susceptibility to Antiseptics Is Conferred by Heterologous Housekeeping Genes. Tansirichaiya S; Reynolds LJ; Cristarella G; Wong LC; Rosendahl K; Roberts AP Microb Drug Resist; 2018 Mar; 24(2):105-112. PubMed ID: 28604259 [TBL] [Abstract][Full Text] [Related]
17. Biochemical and genetic characterization of the action of triclosan on Staphylococcus aureus. Slater-Radosti C; Van Aller G; Greenwood R; Nicholas R; Keller PM; DeWolf WE; Fan F; Payne DJ; Jaworski DD J Antimicrob Chemother; 2001 Jul; 48(1):1-6. PubMed ID: 11418506 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of the Staphylococcus aureus NADPH-dependent enoyl-acyl carrier protein reductase by triclosan and hexachlorophene. Heath RJ; Li J; Roland GE; Rock CO J Biol Chem; 2000 Feb; 275(7):4654-9. PubMed ID: 10671494 [TBL] [Abstract][Full Text] [Related]
19. Small-colony variants: a novel mechanism for triclosan resistance in methicillin-resistant Staphylococcus aureus. Seaman PF; Ochs D; Day MJ J Antimicrob Chemother; 2007 Jan; 59(1):43-50. PubMed ID: 17079243 [TBL] [Abstract][Full Text] [Related]
20. Staphylococcus epidermidis isolated in 1965 are more susceptible to triclosan than current isolates. Skovgaard S; Nielsen LN; Larsen MH; Skov RL; Ingmer H; Westh H PLoS One; 2013; 8(4):e62197. PubMed ID: 23614034 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]